Illumina, Inc. (ILMN) analyst actions
Rating and price-target actions on ILMN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ILMN overview →
2 measured ILMN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications | Press release | +0.07% | -0.24% | |
| Charles Dadswell to step down as General Counsel, Illumina initiates search for successor | Press release | +0.15% | +1.95% |
Keep exploring
More ILMN: earnings → · SEC filings → · ILMN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Perrigo Company plc Ordinary Shares (PRGO) | 916 | +0.04% | 50% |
| PORTOLA PHARMACEUTICALS (PTLA) | 915 | -0.04% | 48% |
| Twist Bioscience Corporation (TWST) | 914 | -0.01% | 50% |
| Boston Scientific Corporation (BSX) | 912 | +0.07% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.